Last Updated on November 11, 2024 by The Health Master
The US Food and Drug Administration (USFDA) has concluded its inspection of Piramal Pharma’s Sellersville manufacturing facility in the United States, the pharmaceutical firm said on April 19.
Piramal Pharma said the US health regulator issued an Establishment Inspection Report (EIR) for its Sellersville manufacturing facility in Pennsylvania.
EIR is the final inspection report of an USFDA inspection.
The inspection was conducted between December 19, 2022 and January 13, 2023.
Piramal Pharma’s Sellersville facility is a fully integrated site, which is involved in the manufacturing and packaging of solid oral dosage forms, liquids, creams and ointments.
Meanwhile, USFDA issued an EIR also for Piramal Pharma’s Lexington unit, in February.
USFDA appeals US federal judge’s block on abortion pill
USFDA withdraws approval for this birth prevention drug
USFDA grants accelerated approval for Skin cancer therapy
USFDA gives nod for Human Trial of drug for the treatment of advanced cancer
USFDA inspection at Alembic completed without any observations: Gujarat
USFDA flags shortage of medication used to treat breathing conditions
Pharmacy Inspectors appointed to check presence of Pharmacists at Medical Stores
HM Haryana urges Centre to provide Vial Monitor indicators for storage of vaccines
Hospital sealed for patient’s death due to Anaesthesia overdose
New Portable Medical Device developed to check vascular health
Threat: Drug mix of Xylazine, Fentanyl
CDSCO: Submit application for license for Class C&D non-notified Medical Devices
Wet Granulation vs Dry Granulation: Understanding the Key Differences
CDSCO revises list of FDCs declared as rational
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon: